Market View Minutes with Michelle: Can Pfizer sustain its record gains for the mid-to-long term?
Your Money with Michelle Martin · MONEY FM 89.3
February 8, 20222m 46s
Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Pfizer is due to release its earnings in the US tonight and the stage is set for what's been dubbed "record-shattering revenues", and analysts believe two new products will bring sales beyond the US$1 billion mark. But can the pharmaceutical giant sustain these gains in the medium to long term? Michelle Martin finds out.
See omnystudio.com/listener for privacy information.